Allergan’s most recent trend suggests a bearish bias. One trading opportunity on Allergan is a Bear Call Spread using a strike $92.50 short call and a strike $97.50 long call offers a potential 16.28% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $92.50 by expiration. The full premium credit of $0.70 would be kept by the premium seller. The risk of $4.30 would be incurred if the stock rose above the $97.50 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Allergan is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Allergan is bearish.
The RSI indicator is at 59.79 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Allergan
[$$] Allergan Agrees to Sell Lap-Band Business
Wed, 30 Oct 2013 04:04:08 GMT
The Wall Street Journal – Allergan reached a deal to sell its lap-band obesity-intervention business to Apollo Endosurgery for as much as $110 million.
U.S./Canada daily earnings hits & misses Oct 29 – 1800 ET
Tue, 29 Oct 2013 22:00:28 GMT
Reuters – The following U.S.- and Canada-listed companies reported earnings on Tuesday. This list shows whether they beat, met or missed Wall Street analysts’ forecasts. It also shows the difference between analysts’ …
Allergan Management Discusses Q3 2013 Results – Earnings Call Transcript
Tue, 29 Oct 2013 21:00:07 GMT
Seeking Alpha – David E. I. Pyott Great. Thanks, Jim. Good morning, ladies and gentlemen. Third quarter sales increased strongly over Q3 of 2012 by 14.0% to local currencies and by 12.9% to U.S. dollars. We’re delighted …
Allergan Beats on Earnings Again
Tue, 29 Oct 2013 15:37:36 GMT
Also on Market Tamer…
Follow Us on Facebook